JP Morgan Chase
PARN

JP Morgan Chase’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

JP Morgan Chase’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-117,170
Closed -$580K – 4345
2015
Q2 		$580K Buy
117,170
+32,752
+39% +$144K ﹤0.01% 3507
2015
Q1 		$414K Buy
84,418
+13,035
+18% +$60.3K ﹤0.01% 3610
2014
Q4 		$296K Buy
+71,383
New +$324K ﹤0.01% 3876

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's PARN Position: Q3 2015 in Review

JP Morgan Chase sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q3 2015, closing a stake of 117,170 shares — an estimated $580K sold.

JP Morgan Chase first reported a position in PARN in Q4 2014 and held it in 3 quarters. The position peaked at $580K in Q2 2015. 10 funds tracked by Wall St. Rank hold PARN as of Q3 2015.

  • JP Morgan Chase reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q3 2015 after selling out during the quarter.
  • JP Morgan Chase sold 117,170 Parnell Pharmaceuticals Holdings Ltd shares in Q3 2015, an estimated $580K.
  • JP Morgan Chase first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2014 and held it in 3 quarters.
  • JP Morgan Chase's Parnell Pharmaceuticals Holdings Ltd position peaked at $580K in Q2 2015.
  • 10 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q3 2015.

Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.